Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 83 of 535 for:    ESCITALOPRAM AND Disorders

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03274817
Recruitment Status : Recruiting
First Posted : September 7, 2017
Last Update Posted : June 19, 2019
Sponsor:
Information provided by (Responsible Party):
NYU Langone Health

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020